| Primary information |
|---|
| ID | antitb_1330 |
| Peptide Name | Human beta casein fragment (54-59) |
| Sequence | VEPIPY |
| N-terminal Modification | Free |
| C-terminal Modification | Free |
| Chemical Modification | None |
| Linear/ Cyclic | Linear |
| Length | 6 |
| Chirality | L |
| Nature | Cationic |
| Source | Protein derived |
| Origin | Human beta casein protein |
| Species | Mycobacterium bovis |
| Strain | Mycobacterium bovis BCG |
| Inhibition Concentartion | MIC = 25μM |
| In vitro/In vivo | in vitro |
| Cell Line | THP 1 cell lines |
| Inhibition Concentartion | Cells treated with 10 mM and 20 mM peptide showed 17.13% and 29.56% increase in clearance of BCG |
| Cytotoxicity | NA |
| In vivo Model | NA |
| Lethal Dose | NA |
| Immune Response | Increase expression of IL-8, MCP-1, MIP-1β, TNF-α |
| Mechanism of Action | NA |
| Target | NA |
| Combination Therapy | NA |
| Other Activities | NA |
| Pubmed ID | 23029305 |
| Year of Publication | 2012 |
| 3-D Structure |  View in Jmol or Download Structure |